The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations
Clinical trial NCT03339778 · COMPLETED
Trial details
- NCT number
- NCT03339778
- Sponsor
- IMMUNOe Research Centers
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-11-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.